SERPASIL 0.25MG
SERPASIL 0.25MG
Discontinued
DIN Number
00005665
Drug Class
Human
Market Date
Dec 31, 1954
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00005665
AIG Number0104657001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02AA02 RESERPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:08.32
Health Canada Classification
ACTIVE INGREDIENTS (1)
RESERPINEActive
Strength: 0.25 MG / TAB
Monograph: RESERPINE